ICU Medical logo
ICU Medical ICUI
$ 122.4 -0.48%

Quarterly report 2026-Q1
added 05-07-2026

report update icon

ICU Medical Income Statement 2011-2026 | ICUI

Annual Income Statement ICU Medical

2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006

Market Cap

3.67 B 3.65 B 2.56 B 4.24 B 5.02 B 4.34 B 3.83 B 4.9 B 4.56 B 2.19 B 1.53 B 1.28 B 952 M 859 M 634 M 422 M 544 M 361 M 588 M -

Shares

24.6 M 24.4 M 24.1 M 23.9 M 21.2 M 20.9 M 20.6 M 20.4 M 19.6 M 16.2 M 15.8 M 15.3 M 14.7 M 14.2 M 13.8 M 13.6 M 14.7 M 14.1 M 14.3 M -

Historical Prices

149 150 106 178 237 208 196 246 231 150 91.9 88.9 57.9 56.8 45.9 31 37 25.5 41.2 41.2

Net Income

732 K -118 M -29.7 M -74.3 M 103 M 86.9 M 101 M 28.8 M 68.6 M 63.1 M 45 M 26.3 M 40.4 M 41.3 M 44.7 M 29.9 M 25 M 24.3 M 23.1 M -

Revenue

2.23 B 2.38 B 2.26 B 2.28 B 1.32 B 1.27 B 1.27 B 1.4 B 1.29 B 379 M 342 M 309 M 314 M 317 M 302 M 283 M 229 M 205 M 188 M -

Cost of Revenue

1.41 B 1.56 B 1.52 B 1.58 B 825 M 810 M 794 M 830 M 867 M 178 M - - - - - - - - - -

Gross Profit

822 M 825 M 740 M 698 M 491 M 461 M 472 M 570 M 426 M 201 M 181 M 151 M 155 M 157 M 142 M 129 M 106 M 89.8 M 78.2 M -

Operating Income

42.8 M 43 M 22.8 M -42.9 M 123 M 98.2 M 107 M 29.8 M -13.3 M 82.9 M 68.6 M 39 M 51.9 M 61.3 M 65.2 M 47.7 M 35.4 M 31.4 M 24.6 M -

Interest Expense

93.3 M 107 M 103 M 70.8 M 858 K 1.75 M 549 K 709 K 2.05 M 118 K 39 K - - - - - - - - -

EBITDA

244 M 262 M 252 M 192 M 213 M 184 M 231 M 264 M 137 M 118 M 99.9 M 63.6 M 71.5 M 80.3 M 66.8 M 65 M 51.1 M 45.6 M 36.4 M -

Operating Expenses

779 M 782 M 717 M 741 M 368 M 363 M 326 M 381 M 355 M 102 M 98.9 M 107 M 103 M 95.2 M 93.9 M 81.3 M 70.8 M 58.4 M 53.6 M -

General and Administrative Expenses

625 M 639 M 607 M 608 M 303 M 284 M 277 M 328 M 304 M 89.4 M 83.2 M 88.9 M 90.4 M 84.6 M 85.3 M 76.6 M 68.2 M 53.6 M 45.5 M -

All numbers in USD currency

Quarterly Income Statement ICU Medical

2026-Q1 2025-Q3 2025-Q2 2025-Q1 2024-Q4 2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1 2010-Q3 2010-Q2 2010-Q1 2009-Q3 2009-Q2 2009-Q1

Shares

24.8 M 24.7 M 24.6 M 24.5 M 24.5 M 24.4 M 24.4 M 24.2 M 24.1 M 24.1 M 24.1 M 24 M 24 M 23.9 M 23.9 M 23.6 M 21.3 M 21.2 M 21.2 M 21.1 M 21.1 M 20.9 M 20.9 M 20.8 M 20.7 M 20.7 M 20.6 M 20.5 M 20.5 M 20.5 M 20.4 M 20.3 M 20.2 M 20 M 19.8 M 18.4 M 16.3 M 16.2 M 16.1 M 16 M 16.1 M 15.9 M 15.8 M 15.7 M 15.6 M 15.3 M 15.2 M 15.1 M 15.1 M 14.7 M 14.6 M 14.5 M 14.5 M 14.3 M 14.2 M 14 M 14.5 M 13.9 M 13.9 M 13.7 M 13.5 M 13.5 M 13.9 M 14.8 M 14.8 M 14.7 M

Net Income

30.1 M -3.4 M 35.3 M -15.5 M - -33 M -21.4 M -39.5 M - 7.24 M -9.93 M -9.81 M - -13.2 M -7.47 M -38.1 M - 31.1 M 28.4 M 23.7 M 26.1 M 25 M 18.9 M 18.9 M 20.6 M 26.6 M 22.8 M 31 M -7.36 M 219 K 31.1 M 4.88 M 49.7 M 136 K -37.1 M 55.9 M 9.51 M 18.8 M 16.6 M 18.2 M 5.46 M 16.3 M 13.6 M 9.69 M 7.37 M 6.43 M 5.88 M 6.66 M 13.3 M 11 M 7.37 M 8.68 M 12.3 M 12.2 M 9.15 M 7.6 M 17.8 M 9.26 M 9.49 M 8.07 M 8.98 M 7.71 M 4.26 M 6.32 M 5.74 M 7.06 M

Revenue

530 M 537 M 549 M 605 M - 589 M 596 M 567 M - 553 M 549 M 569 M - 598 M 561 M 543 M - 336 M 322 M 318 M 320 M 319 M 303 M 632 M 316 M 307 M 312 M 331 M 340 M 327 M 360 M 372 M 370 M 343 M 332 M 248 M 95.7 M 97.1 M 96.7 M 89.9 M 90.4 M 86 M 83.8 M 81.5 M 79.9 M 77.5 M 78.7 M 73.2 M 77.9 M 82.8 M 78.7 M 74.3 M 82.7 M 81.4 M 77.3 M 75.5 M 76.5 M 76.5 M 77.8 M 71.5 M 75.7 M 68.9 M 64.4 M 54 M 53.4 M 54.3 M

Cost of Revenue

324 M 336 M 341 M 395 M - 384 M 389 M 381 M - 369 M 357 M 377 M - 411 M 393 M 374 M - 208 M 198 M 205 M - 205 M 197 M 404 M - 189 M 208 M 196 M - 193 M 209 M 223 M - 232 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Gross Profit

206 M 201 M 208 M 210 M - 205 M 207 M 185 M - 184 M 192 M 192 M - 186 M 168 M 169 M - 128 M 124 M 113 M 120 M 114 M 106 M 228 M 114 M 119 M 104 M 135 M 135 M 135 M 152 M 149 M 137 M 112 M 88.1 M 88.9 M 50.8 M 51.3 M 50.1 M 49.2 M 48.3 M 46.3 M 43.8 M 42.5 M 39.7 M 38.1 M 37.5 M 36 M 38.9 M 41 M 38 M 36.8 M 41.8 M 40.7 M 39.1 M 35 M 36 M 35.6 M 36.2 M 34.6 M 34 M 32.1 M 26.9 M 25 M 25.8 M 26.6 M

Operating Income

13.6 M 13.7 M 10.6 M 12.9 M - 8.24 M 7.69 M -10.7 M - 22.9 M 2.76 M 9.4 M - -467 K -48 K -42.2 M - 38.4 M 34.5 M 26.6 M - 25.5 M 19.6 M 45.6 M - 32.9 M 26.3 M 30.4 M - 2.25 M 31.7 M 4.91 M - -3.7 M -35.9 M -17 M - 22.5 M 22.8 M 23.9 M - 24.8 M 20.3 M 11 M - 8.41 M 8.7 M 9.88 M - 15.4 M 11 M 12 M - 17.5 M 13.5 M 11.4 M - 13.3 M 14 M 12.2 M 14.6 M 11.8 M 6.35 M 7.64 M 8.67 M 10.7 M

Interest Expense

16.5 M 19.8 M 20.5 M 22 M - 24.7 M 23.8 M 23.8 M - 24.2 M 24.1 M 22.5 M - 17.8 M 15.4 M 13.6 M - 168 K 163 K 161 K - 616 K 771 K 967 K - 139 K 139 K 133 K - 283 K 130 K 135 K - 705 K 525 K 513 K - 58 K 48 K - - - - - - - - - - - - - - - - - - - - - - - - - - -

EBITDA

63.6 M 31.4 M 27.5 M 62.3 M - 29.6 M 30 M 44.9 M - 47.9 M 27.2 M 65.1 M - 22.5 M 24.9 M 11 M - 105 M 78.8 M 48.7 M - 89.6 M 35.4 M 88.2 M - 89.9 M 64.1 M 49.4 M - 57.3 M 67.6 M 23.2 M - 43.8 M -6.03 M -5.39 M - 36.8 M 32.4 M 28.7 M - 38 M 29.3 M 15.6 M - 23.1 M 18.4 M 14.6 M - 29.9 M 20.5 M 16.7 M - 31.8 M 23.1 M 16.2 M - 27 M 23 M 16.7 M 27.4 M 20.4 M 10.9 M 18.9 M 16 M 14.3 M

Operating Expenses

193 M 187 M 197 M 197 M - 197 M 200 M 196 M - 161 M 190 M 183 M - 187 M 168 M 211 M - 89.4 M 89.1 M 86.1 M - 88.4 M 86.7 M 182 M - 85.7 M 77.6 M 105 M - 132 M 120 M 144 M - 115 M 124 M 106 M - 28.8 M 27.4 M 25.3 M - 21.5 M 23.4 M 31.5 M - 29.7 M 28.8 M 26.2 M - 25.5 M 27.1 M 24.8 M - 23.2 M 25.5 M 23.6 M - 22.3 M 22.2 M 22.4 M 19.4 M 20.3 M 20.6 M 17.4 M 17.1 M 15.8 M

General and Administrative Expenses

155 M 153 M 159 M 157 M - 163 M 160 M 158 M - 149 M 151 M 153 M - 153 M 159 M 153 M - 74.8 M 73.9 M 72.4 M - 70.9 M 67.2 M 140 M - 65.9 M 67.8 M 72.6 M - 76.6 M 81.8 M 85 M - 76.8 M 85.1 M 64.9 M - 22.4 M 22.5 M 22 M - 20.2 M 20.3 M 20.2 M - 21.8 M 24.3 M 22.5 M - 22.4 M 23.2 M 22.9 M - 20.2 M 22.8 M 20.9 M - 20.4 M 19.7 M 22.9 M 18.3 M 19.4 M 19.7 M 16.8 M 16.5 M 15.1 M

All numbers in USD currency

The income statement is one of the three key financial reports of a company ICU Medical (alongside the balance sheet and the cash flow statement). It shows how the company makes money and what its expenses are:

  • How much revenue the company earned
  • How much it spent on production, personnel, marketing, taxes, etc.
  • What profit remained in the end

Analyzing the income statement helps an investor understand whether the business generates stable and growing profits, how effectively the company controls its expenses, and whether it is capable of generating income in the future. Additionally, this analysis shows how the company copes with crises and economic cycles, and allows assessing the potential for stock price growth and dividend payments.

Features
  • The income statement may include both recurring and one-time items (for example, profit from the sale of assets). It is necessary to separate core metrics from one-off events for accurate analysis.
  • Companies often publish interim reports (e.g., quarterly), which allows for more timely tracking of trends.
  • A combined analysis of the income statement with the balance sheet and cash flow statement provides a comprehensive view of the company’s financial health.

Reports on the profits and losses of other stocks in the Medical instruments industry

Issuer Price % 24h Market Cap Country
The Cooper Companies The Cooper Companies
COO
$ 60.84 0.76 % $ 12.1 B usaUSA
Atrion Corporation Atrion Corporation
ATRI
- - $ 810 M usaUSA
Luminex Corporation Luminex Corporation
LMNX
- - $ 1.75 B usaUSA
iRhythm Technologies iRhythm Technologies
IRTC
$ 114.08 -0.07 % $ 3.65 B usaUSA
Akers Biosciences, Inc. Akers Biosciences, Inc.
AKER
- -9.52 % $ 20.6 M usaUSA
Intuitive Surgical Intuitive Surgical
ISRG
$ 428.24 0.04 % $ 153 B usaUSA
Alcon Alcon
ALC
$ 64.65 1.02 % $ 40.4 B schweizSchweiz
Repro Med Systems Repro Med Systems
KRMD
$ 3.91 -1.75 % $ 181 M usaUSA
LeMaitre Vascular LeMaitre Vascular
LMAT
$ 99.4 -0.1 % $ 2.25 B usaUSA
Masimo Corporation Masimo Corporation
MASI
$ 178.41 0.03 % $ 9.51 B usaUSA
Antares Pharma, Inc. Antares Pharma, Inc.
ATRS
- - $ 955 M usaUSA
Cantel Medical Corp. Cantel Medical Corp.
CMD
- -1.18 % $ 3.4 B usaUSA
CRH Medical Corporation CRH Medical Corporation
CRHM
- - $ 282 M usaUSA
Hill-Rom Holdings, Inc. Hill-Rom Holdings, Inc.
HRC
- -0.05 % $ 10.3 B usaUSA
Ekso Bionics Holdings Ekso Bionics Holdings
EKSO
- - $ 28.6 M usaUSA
Envista Holdings Corporation Envista Holdings Corporation
NVST
$ 23.9 0.21 % $ 4.02 B usaUSA
Varian Medical Systems, Inc. Varian Medical Systems, Inc.
VAR
- -0.02 % $ 16.3 B usaUSA
electroCore electroCore
ECOR
$ 6.3 -2.02 % $ 53.4 K usaUSA
Haemonetics Corporation Haemonetics Corporation
HAE
$ 57.35 0.46 % $ 2.89 B usaUSA
Isoray Isoray
ISR
- 0.03 % $ 108 M usaUSA
Glaukos Corporation Glaukos Corporation
GKOS
$ 143.0 0.6 % $ 6.93 B usaUSA
STAAR Surgical Company STAAR Surgical Company
STAA
$ 31.91 -0.31 % $ 1.58 B usaUSA
STERIS plc STERIS plc
STE
$ 216.15 0.08 % $ 21.3 B usaUSA
Teleflex Incorporated Teleflex Incorporated
TFX
$ 130.56 0.21 % $ 5.83 B usaUSA
InfuSystem Holdings InfuSystem Holdings
INFU
$ 8.43 -2.37 % $ 174 M usaUSA
Microbot Medical Microbot Medical
MBOT
$ 1.92 3.69 % $ 87.9 M israelIsrael
Milestone Scientific Milestone Scientific
MLSS
$ 0.34 -1.02 % $ 27.9 M usaUSA
Merit Medical Systems Merit Medical Systems
MMSI
$ 62.37 -0.3 % $ 3.69 B usaUSA
Utah Medical Products Utah Medical Products
UTMD
$ 63.24 -0.72 % $ 205 M usaUSA
West Pharmaceutical Services West Pharmaceutical Services
WST
$ 301.21 0.34 % $ 21.8 B usaUSA
Pulse Biosciences Pulse Biosciences
PLSE
$ 25.45 -6.09 % $ 1.72 B usaUSA
DENTSPLY SIRONA DENTSPLY SIRONA
XRAY
$ 10.1 -3.03 % $ 2.01 B usaUSA
Retractable Technologies Retractable Technologies
RVP
$ 0.69 -0.01 % $ 20.7 M usaUSA
Pro-Dex Pro-Dex
PDEX
$ 57.73 -1.57 % $ 190 M usaUSA
Predictive Oncology Predictive Oncology
POAI
- - $ 31.1 M usaUSA
BioLife Solutions BioLife Solutions
BLFS
$ 20.76 -1.42 % $ 991 M usaUSA
Stereotaxis Stereotaxis
STXS
$ 1.89 -2.83 % $ 172 M usaUSA
Baxter International Baxter International
BAX
$ 17.62 -0.96 % $ 9.04 B usaUSA
ResMed ResMed
RMD
$ 204.91 1.21 % $ 29.9 B usaUSA
AtriCure AtriCure
ATRC
$ 28.69 1.92 % $ 1.37 B usaUSA
Harvard Bioscience Harvard Bioscience
HBIO
$ 5.34 -3.26 % $ 237 M usaUSA
NeuroMetrix NeuroMetrix
NURO
- 5.05 % $ 9.02 M usaUSA
AngioDynamics AngioDynamics
ANGO
$ 10.98 -0.45 % $ 449 M usaUSA
Becton, Dickinson and Company Becton, Dickinson and Company
BDX
$ 143.99 -0.33 % $ 41.4 B usaUSA
Nephros Nephros
NEPH
$ 3.2 -4.23 % $ 34 M usaUSA
OraSure Technologies OraSure Technologies
OSUR
$ 3.04 3.05 % $ 223 M usaUSA
Repligen Corporation Repligen Corporation
RGEN
$ 106.8 3.31 % $ 6.01 M usaUSA